This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gadebusch, H. Articles by Renz, K. Search for Related Content PubMed PubMed Citation Articles by Gadebusch, H. Articles by Renz, K.

 Previous Article  |  Next Article 

Infect Immun. 1971 July; 4(1): 50-53
Copyright © 1971 American Society for Microbiology. All Rights Reserved.

Epicillin: Experimental Chemotherapy, Pharmacodynamics, and Susceptibility Testing

Squibb Institute for Medical Research, New Brunswick, New Jersey 08903

ABSTRACT

Epicillin exhibits excellent therapeutic activity when administered orally or subcutaneously to mice infected with a variety of pathogenic bacteria. These included single strains of Streptococcus pyogenes, non-penicillinase-producing Staphylococcus aureus, Proteus mirabilis, Escherichia coli, Salmonella schottmuelleri, and Pseudomonas aeruginosa, strains of microorganisms selected as typical of those that frequently cause serious clinical infections. In oral chemotherapeutic comparisons of tetracycline, chloramphenicol, cephalexin, ampicillin, and epicillin, the latter, with but minor exceptions, exhibited activity comparable to that of most of the other antibiotics studied. Oral administration to mice of a loading dose of epicillin or ampicillin resulted in similar peak blood levels and decay curves. The concentration in urine and the excretion rates were significantly higher in epicillin than in ampicillin-treated animals. Presumptive evidence suggests that the inter-pretation of zone diameters obtained with 10-µg epicillin discs should be the same as is used for 10-µg ampicillin discs.